1 results match your criteria: "The First Affiliated Hospital of Nanjing Medical University300 Guangzhou Road[Affiliation]"
MicroRNA-625 inhibits the proliferation and increases the chemosensitivity of glioma by directly targeting AKT2.
Am J Cancer Res
September 2017
Department of Neurosurgery, The First Affiliated Hospital of Nanjing Medical University300 Guangzhou Road, Nanjing 210029, Jiangsu Province, People's Republic of China.
Glioma is a malignant tumor for which new therapies are needed. Growing evidence has demonstrated that microRNAs (miRNAs) have a major effect on glioma development. Here, we aimed to characterize a novel anti-cancer miRNA, miR-625, by investigating its expression, function, and mechanism of action in glioma progression.
View Article and Find Full Text PDF